Welcome back to Stockhouse Member Sign In
Sign in with one of the following accounts.
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Use one of the following accounts.
Macfaust, my guess is that the drug referred to in the BBC article is most likely to be one based on IL-17 inhibition like the new IL-17 inhibitor MABs that are in Phase 3 testing for psoriasis.
Receive investor kits and email updates from Stockhouse and directly from these companies.